Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity

MLA

Daniel Jenson, et al. “Dopamine and Norepinephrine Receptors Participate in Methylphenidate Enhancement of in Vivo Hippocampal Synaptic Plasticity.” Neuropharmacology, pp. 23–32. EBSCOhost, https://doi.org/10.1016/j.neuropharm.2014.10.029. Accessed 24 Jan. 2025.

APA

Daniel Jenson, Amber T. Levine, John I. Broussard, Kechun Yang, Jianrong Tang, Alexandra Acevedo-Rodriguez, & John A. Dani. (n.d.). Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity. Neuropharmacology, 23–32. https://doi.org/10.1016/j.neuropharm.2014.10.029

Chicago

Daniel Jenson, Amber T. Levine, John I. Broussard, Kechun Yang, Jianrong Tang, Alexandra Acevedo-Rodriguez, and John A. Dani. 2025. “Dopamine and Norepinephrine Receptors Participate in Methylphenidate Enhancement of in Vivo Hippocampal Synaptic Plasticity.” Neuropharmacology, 23–32. Accessed January 24. doi:10.1016/j.neuropharm.2014.10.029.